Home Science The Role of Cardiotrition® Booster in High-Risk Cardiovascular Populations:

The Role of Cardiotrition® Booster in High-Risk Cardiovascular Populations:

Cardiotrition® Booster is an advanced mitochondrial bioenergetic formulation designed to support cardiac energy production and myocardial recovery in high-risk cardiovascular patients, including post-myocardial infarction patients, individuals with heart failure, diabetic cardiomyopathy, chronic statin users, and pre-operative cardiac candidates.

This study highlights the formulation's complementary mechanisms of action, combining liposomal Coenzyme Q10, liposomal R-alpha lipoic acid, and enhanced acetyl-L-carnitine with CardioDrone® cardiac-targeting technology. Findings demonstrated enhanced ATP regeneration, reaching much more increase compared  with CoQ10 monotherapy. Additionally, post-MI patients receiving Cardiotrition® Booster showed significantly greater myocardial functional recovery and a reduction in recovery time from 32 to 16 days compared with placebo.

With improved bioavailability, targeted cardiac delivery, and a favorable safety profile across two controlled trials, Cardiotrition® Booster represents a promising adjunctive strategy to support mitochondrial function, cardiac energy metabolism, and myocardial recovery in high-risk cardiovascular populations, while complementing standard guideline-directed medical therapy.

Related Products

YOUR CART
Free shipping on orders over three items

Your cart is empty